Icon of the Instituts for Quality and Efficiency in Health Care

Report

Health economic evaluation of venlafaxine, duloxetine, bupropion, and mirtazapine compared to further prescribable pharmaceutical treatments

Status
Status: Commission completed
Project no.
G09-01
Last updated

Report documents

  1. Executive summary of the final report

    Health economic evaluation of venlafaxine, duloxetine, bupropion, and mirtazapine compared to further prescribable pharmaceutical treatments

    published on
    Document type
    PDF document, 292 kB, EN, not accessible
    Download file : Executive summary of the final report (PDF document, 292 kB, EN, not accessible)

  2. Final report

    Health economic evaluation of venlafaxine, duloxetine, bupropion, and mirtazapine compared to further prescribable pharmaceutical treatments

    published on
    Document type
    PDF document, 5 MB, DE, not accessible
    Download file : Final report (PDF document, 5 MB, DE, not accessible)

  3. Documentation and evaluation of comments on the preliminary report

    Health economic evaluation of venlafaxine, duloxetine, bupropion, and mirtazapine compared to further prescribable pharmaceutical treatments

    published on
    Document type
    PDF document, 2 MB, DE, not accessible
    Download file : Documentation and evaluation of comments on the preliminary report (PDF document, 2 MB, DE, not accessible)

  4. Executive summary of the preliminary report

    Health economic evaluation of venlafaxine, duloxetine, bupropion, and mirtazapine compared to further prescribable pharmaceutical treatments

    published on
    Document type
    PDF document, 318 kB, DE, not accessible
    Download file : Executive summary of the preliminary report (PDF document, 318 kB, DE, not accessible)

  5. Preliminary report

    Health economic evaluation of venlafaxine, duloxetine, bupropion, and mirtazapine compared to further prescribable pharmaceutical treatments

    published on
    Document type
    PDF document, 4 MB, DE, not accessible
    Download file : Preliminary report (PDF document, 4 MB, DE, not accessible)

  6. Annex 1 to the preliminary report

    Health economic evaluation of venlafaxine, duloxetine, bupropion, and mirtazapine compared to further prescribable pharmaceutical treatments

    published on
    Document type
    PDF document, 634 kB, not accessible
    Download file : Annex 1 to the preliminary report (PDF document, 634 kB, not accessible)

  7. Annex 2 to the preliminary report

    Health economic evaluation of venlafaxine, duloxetine, bupropion, and mirtazapine compared to further prescribable pharmaceutical treatments

    published on
    Document type
    ZIP document, 27 kB
    Download file : Annex 2 to the preliminary report (ZIP document, 27 kB)

  8. Report plan version 1.0

    Health economic evaluation of venlafaxine, duloxetine, bupropion, and mirtazapine compared to further prescribable pharmaceutical treatments

    published on
    Document type
    PDF document, 431 kB, DE, not accessible
    Download file : Report plan version 1.0 (PDF document, 431 kB, DE, not accessible)

  9. Documentation and appraisal of comments on the preliminary report plan

    Health economic evaluation of venlafaxine, duloxetine, bupropion, and mirtazapine compared to further prescribable pharmaceutical treatments

    published on
    Document type
    PDF document, 4 MB, DE, not accessible
    Download file : Documentation and appraisal of comments on the preliminary report plan (PDF document, 4 MB, DE, not accessible)

  10. Preliminary report plan

    Health economic evaluation of venlafaxine, duloxetine, bupropion, and mirtazapine compared to further prescribable pharmaceutical treatments

    published on
    Document type
    PDF document, 370 kB, DE, not accessible
    Download file : Preliminary report plan (PDF document, 370 kB, DE, not accessible)

Press releases

IQWiG: First health economic evaluation completed

Report on health economic evaluation of antidepressants provides very helpful results / Discussion is still pending about the future role of health economic evaluations in the health care system
Press release

Project details

Project no.
G09-01
Commission
Commission awarded on 17.12.2009 by the Federal Joint Committee (GBA).
Report type
Report
Status
Commission completed
Department/Division
Health Economics
Topic
Mental and emotional wellbeing

Contact

Press contact

+49 221 356850

press@iqwig.de

Info Service (German)

Subscribe to daily updated information on projects, calls for tender, current vacancies and events as well as our press releases.

Register

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.

Contact form

Print page